Moreover, a recent study showed that a subset of AIRE-deficient patients who developed autoantibodies specific for IFNα, especially IFN-α1/13, IFN-α5, and IFN-α14, were less likely to develop T1D, whereas patients who failed to generate these antibodies developed T1D (304). This evidence concerns the gene IFNA1 and type 1 diabetes mellitus.